ARTICLES BY ARNAUD DELADERIERE
-
![vacation-GettyImages-1430503053]( "New Group Wants 'Phase-Appropriate' Thinking To Retire")
New Group Wants 'Phase-Appropriate' Thinking To Retire9/4/2025Decisions in cell and gene therapy are not about aligning with arbitrary clinical phases but about balancing risk.
Arnaud Deladeriere
Arnaud Deladeriere, Ph.D., is principal consultant at Cell&Gene Consulting Inc. Previously, he was head of MSAT and Manufacturing at Triumvira Immunologics, and before that, manufacturing manager at C3i. He received his Ph.D. in biochemistry from the University of Cambridge.